Seymour Albert 4
4 · Homology Medicines, Inc. · Filed Sep 8, 2023
Insider Transaction Report
Form 4
Seymour Albert
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-09-06$1.15/sh−1,448$1,665→ 150,874 total - Exercise/Conversion
Restricted Stock Units
2023-09-06−4,620→ 9,380 total→ Common Stock (4,620 underlying) - Exercise/Conversion
Common Stock
2023-09-06+4,620→ 152,322 total
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.
- [F3]The RSUs will vest and settle as to one third of the RSUs on each of the first three anniversaries of September 6, 2022 so that such RSUs will become fully vested on September 6, 2025. The RSUs have no expiration date.